 SAN DIEGO and TORONTO, June 01, 2021 GLOBE NEWSWIRE -- Aptose Biosciences Inc. Aptose or the Company NASDAQ: APTO, TSX: APS, a clinical-stage company developing highly differentiated therapeutics that target the underlying mechanisms of cancer, today announced the voting results from the Companys annual and special meeting of shareholders held today, June 1, 2021 the Meeting. A total of 72.83 of the issued and outstanding common shares of the Company were represented by shareholders present or represented by proxy at the Meeting. 